Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02561585 · ClinicalTrials.gov registry record · Phase 2
LEO 124249 Ointment in the Treatment of Alopecia Areata
A Phase 2 study, sponsored by LEO Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT02561585 is a Phase 2 study that has completed, run by LEO Pharma. The registered enrollment target is 40 participants.
The verdict
NCT02561585, a Phase 2 study, has completed, sponsored by LEO Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
This clinical trial attempts to investigate the efficacy and safety of LEO 124249 ointment in the treatment of alopecia areata and the molecular disease mechanism and biomarkers.
Interventions
- OTHER Vehicle
- DRUG LEO 124249
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02561585
The ClinicalTrials.gov registry entry for NCT02561585 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LEO Pharma, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT02561585 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02561585 about?
NCT02561585 is a clinical study titled "LEO 124249 Ointment in the Treatment of Alopecia Areata". This clinical trial attempts to investigate the efficacy and safety of LEO 124249 ointment in the treatment of alopecia areata and the molecular disease mechanism and biomarkers.
What is the current status of trial NCT02561585?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2016-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02561585?
The interventions under investigation include: Vehicle (OTHER), LEO 124249 (DRUG).
Who is sponsoring clinical trial NCT02561585?
This trial is sponsored by LEO Pharma, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.